Align Technology, Inc.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
What does it do?
Align Technology makes Invisalign — those clear plastic trays that straighten teeth instead of metal braces. If you've ever seen someone quietly pop a retainer out before eating, that's likely an Invisalign aligner. The company also makes iTero scanners, which are the 3D digital cameras dentists and orthodontists use to scan your mouth instead of making you bite into that goopy mold. Think of Align as the company that turned orthodontics from a metal-and-wire experience into something almost invisible.
Invisalign has become the default brand name in clear aligners — like Kleenex for tissues — which gives Align enormous pricing power in a market that is still far from fully penetrated globally. Only a small fraction of the 500+ million people worldwide who need orthodontic treatment actually get it, meaning the runway for growth is still very long. With dentists and orthodontists increasingly shifting to digital workflows, Align's scanner business also puts it at the center of a broader tech transformation in dental care.
How does it make money?
Align makes money in two main ways. First and biggest is its Clear Aligner segment — doctors order Invisalign treatment packages for their patients, and Align charges per case, with prices ranging roughly from a few hundred to over a thousand dollars per case depending on complexity. Second is its Systems and Services segment, which sells and leases iTero intraoral scanners to dental practices and charges ongoing service fees. With $4 billion in annual revenue, the aligner business is the dominant earner, but the scanner business matters because every iTero scanner installed is essentially a sales funnel that makes it easier for doctors to prescribe Invisalign.
Why do investors care?
The core growth story is global expansion — most of Align's growth opportunity lies outside the US, particularly in underpenetrated markets like China, Latin America, and Southeast Asia where orthodontic treatment rates are still very low. Investors are also watching whether Align can push Invisalign deeper into the general dentist channel, not just specialists, which would massively expand the number of providers prescribing it. For the thesis to work, macroeconomic pressure on consumer spending needs to ease, since Invisalign is often an elective, out-of-pocket expense that consumers cut back on when budgets tighten. A continued recovery in case volumes after a post-COVID demand slowdown is the key near-term signal.
Deep Dive
MemberA full investor briefing on Align Technology, Inc. — history, leadership, risks, and outlook.